Eledon Pharmaceuticals Inc

Market Cap

$290M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.41+$1.79 (+110.49%)

Jun 5, 2026

52W High $4.3652W Low $1.39

Company Details

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to...

CEO

—

IPO Date

Sep 17, 2014

Website

eledon.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$78M

EPS (Diluted)

Free Cash Flow

-$69M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 13, 2026

FY 2025

Mar 19, 2026

Q4 2025

Mar 19, 2026

$0-100.0%

Q3 2025

Nov 14, 2025

Q2 2025

Aug 14, 2025

$0-100.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee